Your browser doesn't support javascript.
loading
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.
Lee, J H; Saw, R P; Thompson, J F; Lo, S; Spillane, A J; Shannon, K F; Stretch, J R; Howle, J; Menzies, A M; Carlino, M S; Kefford, R F; Long, G V; Scolyer, R A; Rizos, H.
Afiliação
  • Lee JH; Faculty of Medicine and Health Sciences, Macquarie University, Macquarie Park, NSW; Melanoma Institute Australia, Wollstonecraft, NSW.
  • Saw RP; Melanoma Institute Australia, Wollstonecraft, NSW; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW.
  • Thompson JF; Melanoma Institute Australia, Wollstonecraft, NSW; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW.
  • Lo S; Melanoma Institute Australia, Wollstonecraft, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW.
  • Spillane AJ; Melanoma Institute Australia, Wollstonecraft, NSW; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW.
  • Shannon KF; Melanoma Institute Australia, Wollstonecraft, NSW; Chris O'Brien Lifehouse, Camperdown, NSW.
  • Stretch JR; Melanoma Institute Australia, Wollstonecraft, NSW.
  • Howle J; Crown Princess Mary Cancer Centre, Westmead and Blacktown hospitals, Wentworthville, NSW.
  • Menzies AM; Melanoma Institute Australia, Wollstonecraft, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW.
  • Carlino MS; Melanoma Institute Australia, Wollstonecraft, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW; Crown Princess Mary Cancer Centre, Westmead and Blacktown hospitals, Wentworthville, NSW.
  • Kefford RF; Faculty of Medicine and Health Sciences, Macquarie University, Macquarie Park, NSW; Melanoma Institute Australia, Wollstonecraft, NSW; Crown Princess Mary Cancer Centre, Westmead and Blacktown hospitals, Wentworthville, NSW.
  • Long GV; Melanoma Institute Australia, Wollstonecraft, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW; Northern Sydney Cancer Centre, Royal North Shore Hospital, St Leonards, NSW.
  • Scolyer RA; Melanoma Institute Australia, Wollstonecraft, NSW; Sydney Medical School, The University of Sydney, Camperdown, NSW; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Rizos H; Faculty of Medicine and Health Sciences, Macquarie University, Macquarie Park, NSW; Melanoma Institute Australia, Wollstonecraft, NSW. Electronic address: helen.rizos@mq.edu.au.
Ann Oncol ; 30(5): 815-822, 2019 05 01.
Article em En | MEDLINE | ID: mdl-30860590
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / DNA Tumoral Circulante / Melanoma / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / DNA Tumoral Circulante / Melanoma / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2019 Tipo de documento: Article